Difference between revisions of "Bupropion-moclobemide"
From Psychiatrienet
| Line 3: | Line 3: | ||
| to = moclobemide | | to = moclobemide | ||
| stop = | | stop = | ||
| − | + | {{StopBupropion}} | |
| − | |||
| start = | | start = | ||
* '''Day 1-7:''' wash-out period of one week is necessary. | * '''Day 1-7:''' wash-out period of one week is necessary. | ||
| Line 11: | Line 10: | ||
* '''Day 15:''' if necessary, increase moclobemide to 600 mg/day. | * '''Day 15:''' if necessary, increase moclobemide to 600 mg/day. | ||
| − | | | + | | info = |
{{caveSS}} | {{caveSS}} | ||
| − | |||
}} | }} | ||
Revision as of 13:40, 7 October 2015
| ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
Switch medication from bupropion to moclobemide.[1] [2]
Stop bupropion - Day 1: Stop bupropion.
- bupropion can be stopped abruptly for every dosage.[3]
Start moclobemide- Day 1-7: wash-out period of one week is necessary.
- Day 8: start moclobemide with 150 mg/day.
- Day 12: increase moclobemide to 300 mg/day.
- Day 15: if necessary, increase moclobemide to 600 mg/day.
More information- Occurrence of the serotonin syndrome is possible without wash-out period.
- ↑ Switches are based on literature references on this page and expert opinions of the authors. The authors have used pharmacokinetic and receptor affinity properties to determine the switch schedules
- ↑ Stahl, S. M. (2013). Stahl's essential psychopharmacology: Neuroscientific basis and practical applications (4th ed.). Cambridge University Press.
- ↑ Multidisciplinair document Afbouwen Overige Antidepressiva 2023
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
